Clinical Spectrum and Genetic Mechanism of GLUT1-DS. Yasushi ITO (Tokyo Women s Medical University, Japan)

Similar documents
variant led to a premature stop codon p.k316* which resulted in nonsense-mediated mrna decay. Although the exact function of the C19L1 is still

Objectives. Genetics and Rett syndrome: As easy as apple pie! Chromosome to gene to protein

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Ketogenic Diet therapy in Myoclonic-Atonic Epilepsy (MAE)

Prof. dr Michèl A. Willemsen. Radboud university medical center Department of Pediatric Neurology Nijmegen, The Netherlands Milano, Oct 2016

Single Gene (Monogenic) Disorders. Mendelian Inheritance: Definitions. Mendelian Inheritance: Definitions

JULY 21, Genetics 101: SCN1A. Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology

Product Description SALSA MLPA Probemix P138-C1 SLC2A1-STXBP1 To be used with the MLPA General Protocol.

GENOTYPE-PHENOTYPE CORRELATIONS IN GALACTOSEMIA COMPLICATIONS COMPLICATIONS COMPLICATIONS LONG-TERM CHRONIC COMPLICATIONS WITH NO CLEAR CAUSE

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Genetics of Hereditary Spastic Paraplegia Dr. Arianna Tucci

Basic Definitions. Dr. Mohammed Hussein Assi MBChB MSc DCH (UK) MRCPCH

for a bright reaching resources

Computational Systems Biology: Biology X

Case presentations from diagnostic exome sequencing results in ion channels M. Koko, U. Hedrich, H. Lerche DASNE meeting 2017, Eisenach

Human Genetic Disorders

Concurrent Practical Session ACMG Classification

Lab Activity 36. Principles of Heredity. Portland Community College BI 233

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Non-Mendelian inheritance

Clinical Summaries. CLN1 Disease, infantile onset and others

Dr. Sarah Weckhuysen, MD, PhD. Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Advances in genetic diagnosis of neurological disorders

Sialic Acid Storage Diseases

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG)

Gaucher disease 3/22/2009. Mendelian pedigree patterns. Autosomal-dominant inheritance

Deciphering Developmental Disorders (DDD) DDG2P

A guide to understanding variant classification

SEX-LINKED INHERITANCE. Dr Rasime Kalkan

GENETICS AND TREATMENT OF DYSTONIA

Lab Activity Report: Mendelian Genetics - Genetic Disorders

Distal renal tubular acidosis: genetic and clinical spectrum

MEDICAL GENOMICS LABORATORY. Non-NF1 RASopathy panel by Next-Gen Sequencing and Deletion/Duplication Analysis of SPRED1 (NNP-NG)

BIOL2005 WORKSHEET 2008

THE ROLE OF CFTR MUTATIONS IN CAUSING CYSTIC FIBROSIS (CF)

Genome Summary. Sequencing Coverage: Variation Counts: Known Phenotype Summary: 131 disease or trait variations are found in this genome

CANCER GENETICS PROVIDER SURVEY

Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016

Chapter 4 PEDIGREE ANALYSIS IN HUMAN GENETICS

ICD-9 to ICD-10 Conversion of Epilepsy

Human inherited diseases

BIOCHEMICAL AND MOLECULAR HETEROGENEITY IN CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY

Thalassemias. Emanuela Veras, M.D. 01/08/2006

THIAMINE TRANSPORTER TYPE 2 DEFICIENCY

CLINICAL SIGNS SUGGESTIVE OF A NEUROMETABOLIC DISEASE. Bwee Tien Poll-The Amsterdam UMC The Netherlands

An approach to movement disorders. Kailash Bhatia, DM, FRCP Professor of Clinical Neurology Institute of Neurology Queen Square, London

NGS in neurodegenerative disorders - our experience

Hyperammonemia in Pediatric Clinics: A review of ornithine transcarbamylase deficiency (OTCD) based on our case studies

Pedigree Construction Notes

A Comprehensive Study of TP53 Mutations in Chronic Lymphocytic Leukemia: Analysis of 1,287 Diagnostic CLL Samples

CHAPTER 10 BLOOD GROUPS: ABO AND Rh

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider

Human Molecular Genetics Prof. S. Ganesh Department of Biological Sciences and Bioengineering Indian Institute of Technology, Kanpur

A modified Atkins diet is promising as a treatment for glucose transporter type 1 deficiency syndrome

D-glucose, the essential fuel for brain metabolism,

How many disease-causing variants in a normal person? Matthew Hurles

Chapter 16 Mutations. Practice Questions:

Characteristic phasic evolution of convulsive seizure in PCDH19-related epilepsy

Index. derm.theclinics.com. Note: Page numbers of article titles are in boldface type.

Childhood epilepsy: the biochemical epilepsies. Dr Colin D Ferrie Consultant Paediatric Neurologist Leeds General Infirmary

Human Blood Groups. ABO Blood Grouping 5/1/12. Dr Badri Paudel Landsteiner s Rule

Dr.Abdolreza Afrasiabi

Familial dystonia with cerebral calcification

Report on GLUT1 Deficiency Syndrome Conference

SETPEG GENETIC TESTING GUIDELINES Version 1.0, 5 th October 2017

Genetic Disorders. PART ONE: Detecting Genetic Disorders. Amniocentesis Chorionic villus sampling Karyotype Triple Screen Blood Test

Genome Summary. Sequencing Coverage: Variation Counts: Known Phenotype Summary: 152 disease or trait variations are found in this genome

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

What we know about Li-Fraumeni syndrome

Sotos syndrome. Nazneen Rahman Institute of Cancer Research

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Human Genetic Diseases (Ch. 15)

Epilepsy Syndromes: Where does Dravet Syndrome fit in?

NGS panels in clinical diagnostics: Utrecht experience. Van Gijn ME PhD Genome Diagnostics UMCUtrecht

Pondering Epilepsy Classification (actually a few thoughts on the impact of genetic analyses of the epilepsies) Genetics of Epilepsies

Chinese cases of early infantile epileptic encephalopathy: a novel mutation in the PCDH19 gene was proved in a mosaic male- case report

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi

Genetics After Mendel

Metabolic Liver Disease

Classification of Seizures. Generalized Epilepsies. Classification of Seizures. Classification of Seizures. Bassel F. Shneker

MMB (MGPG) Non traditional Inheritance Epigenetics. A.Turco

Juvenile Huntington Disease

Tay Sachs, Cystic Fibrosis, Sickle Cell Anemia and PKU. Tay Sachs Disease (also called Hexosaminidase deficiency)

Figure 1: Transmission of Wing Shape & Body Color Alleles: F0 Mating. Figure 1.1: Transmission of Wing Shape & Body Color Alleles: Expected F1 Outcome

Movement disorders: The border between the psychogenic and the neurological. Chiclana G, Ojeda J, Mata M, Chiclana C, Gutiérrez G, Miralles A,.

Riunione Regionale SIN Campania

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Human Genetic Diseases. AP Biology

Genetics and Genomics in Endocrinology

Movement disorders in childhood: assessment and diagnosis. Lucinda Carr

Dr. Ayman Mohsen Mashi, MBBS Consultant Hematology & Blood Transfusion Department Head, Laboratory & Blood Bank King Fahad Central Hospital, Gazan,

Welcome to the Genetic Code: An Overview of Basic Genetics. October 24, :00pm 3:00pm

The laws of Heredity. Allele: is the copy (or a version) of the gene that control the same characteristics.

Corporate Medical Policy

Section Chapter 14. Go to Section:

The Complexity of Simple Genetics

Evaluation and management of drug-resistant epilepsy

Genotype-Phenotype in Egyptian Patients with Nephropathic Cystinosis. (December 2012 report)

Transcription:

Clinical Spectrum and Genetic Mechanism of GLUT1-DS Yasushi ITO (Tokyo Women s Medical University, Japan)

Glucose transporter type 1 (GLUT1) deficiency syndrome Mutation in the SLC2A1 / GLUT1 gene Deficiency of GLUT1 protein Impaired Glucose transport into the brain Failure of Energy production in the brain Impaired Brain functions (Metabolic Encephalopathy)

GLUT1 deficiency syndrome is characterized by l early-onset Epilepsy Paroxysmal abnormal eye movement, l subsequent Developmental delay, Paroxysmal / Static spasticity, ataxia, and dystonia, Other paroxysmal phenomena.

Phenotypic Spectrum of GLUT1-DS Mullen et al, 2010 Paroxysmal Exerciseinduced Dyskinesia Movement Disorder Epilepsy Idiopathic Generalized Epilepsy (IGE) Mild Mild Ataxia Epilepsy and Movement Disorder Focal Epilepsy Pharmacoresistant IGE Complex Movement Disorders with a combination of Ataxia, Spasticity, and Dystonia GLUT1 Encephalopathy Myoclonic- Astatic Epilepsy Intractable Infantile Seizures Severe Severe

Broad Clinical Spectrum of GLUT1-DS l Paroxysmal exercise-induced dyskinesia (PED) l Early-onset absence epilepsy (EOAE) l Myoclonic astatic epilepsy (MAE) l Alternating hemiplegia of childhood (AHC) l Dystonic tremor l Hemolytic anemia with Hereditary stomatocytoses

Phenotypic Spectrum of GLUT1-DS based on the hypothetical Residual GLUT1 Function in the Blood-Brain Barrier Wang et al, 2005 Phenotype Residual function Minimal 75-100% Mild Moderate (Classic) Severe Embryonic lethal Mutation / Remarks l heterozygous Missense mutation l triggered by Environmental factors that inhibit GLUT1 transport activity 50-75% l heterozygous Missense mutation 50% l hemizygote; Large deletion, Nonsense, Frameshift, and Splice-site mutation 25-50% l compound heterozygous mutation 0-25% l homozygous mutation

Relations between Genotype and Phenotype in GLUT1-DS patients Leen et al, 2010 Type A (n=21) B (n=30) C (n=6) Mutation Missense Nonsense, Frame shift, Splice site, or translation inhibition Multiple exon deletion Mild Mental Retardation 79% 26% Movement Disorders 63% 88% Early-onset Classical Phenotype 52% 63% 100% Non-Classical Phenotype 20% 14% 0%

Hereditary Pattern of GLUT1-DS l GLUT1-DS transmission is mostly sporadic, but several familial cases have also been reported. l Familial GLUT1-DS is mainly inherited in an autosomal dominant manner, but there are rare cases of autosomal recessive inheritance or parental mosaicism.

Activities of Daily Living (ADL) in Patients with GLUT1-DS A nationwide survey of GLUT1-DS in Japan (Male 23; Female 23: 3-35 yrs) Bathing Grooming Toile0ng Locomo0on Dressing Feeding Independence Preparing Watching Par0al assistance Total assistance 0% 20% 40% 60% 80% 100% 15% of patients needed total assistance to perform ADL, 30% needed partial assistance in all ADL except for eating, but 40% patients lead an independent life.

A Japanese Family Case with GLUT1-DS caused by S324L mutation in SLC2A1 Normal mentality, Infant-onset, pharmacosensitive partial epilepsy index case Mild mental retardation, Infant-onset, pharmacosensitive partial epilepsy, PED Mild ataxia 42y Case 2 16y 5y 3y Case 1 Case 3 Case 4 Borderline mentality, Infant-onset, pharmacosensitive generalized epilepsy, Adult-onset paroxysmal dystonia Moderate developmntal delay, No epilepsy

Clinical Summary of previously reported 15 Families with Autosomal dominant GLUT1-DS Family No. Anticipation of Mutation Age Phenotype Accel- Severity of eration ranges of Age Amino-acid Type (years) MR Epi PED Others MR Epi Sympt oms at onset PED in Upper Generation Reduced Penetrance 1 S324L Missence 3 to 42 ± ~ ++ + + Ataxia +? + + + 5) 2 G91D Missence 10 to 46 + ~ ++ + - Ataxia, Spascity + + +? 6) 7) 3 R126H Missence 8 to 78 - ~ +++ + - Ataxia + + + + 6) 8) 4 R126C Missence 1 & 31 ND + - Apnea, Abnormal eye movement ND ND +? 9) 5 G314S Missence 19 to 67 - ~ + + + + -? - - + 6) 10) 6 A275T Missence 7 to 44? - + Dystonia, Chorea? - + + + 10) 7 S95I Missence 5 to 70 - ~ + + + -?? + + + 6) 11) 8 R126C Missence 13 & 34 + + - Ataxia - - +? 2) 9 R93W Missence 10 &? - ~ +++ + - Chorea + - +? 2) 10 S324L Missence 28 to 83 - ~ ± + + Ataxia + +? + + - 6) 12) 11 R223P Missence 22 to 54 - + + - +? + + + 6) 12) 12 M344T Missence 14 &? + ~ +++ + - Ataxia + + + + 13) 13 c.18+1g>a Splice site 5 &? - ~ + + - + + + + 2) 14 c.746del; 746-747ins9 Deletion/ Insertion 15 Q282_S285del Deletion 9 to 60 - ~ + + + 12 & 16 + ~ +++ + - Ataxia 2) Ref. No Hemolytic anemia + + + + + 6) 10) +, present; -, absent?, unclear; ND, not described; +++, severe MR; ++, moderate MR; +, mild MR: ±, bordeline mentality; -, normal mentality; MR, mental retardation; Epi, epilepsy; PED, paroxysmal exercise-induced dyskinesia.

Autosomal Recessive Familial GLUT1-DS % of 3-OMG RBC glucose uptake compared to an intra-assay control sample Family 1 Fa1 Mo1 Fa2 Mo2 87% Cousin 83% 84% Family 2 Pa2 66% Pa3 63% 52% ±8.94 Rotstein et al, 2010 Pa1 Phenotype Normal 36% Minimal / Mild Moderate / Classic Severe Embryonic lethal de novo mutation in the paternally derived allele

The GLUT1 Protein Transmembrane Configuration with the Locations of the R126L, K256V and R468W missense mutations Family 1 Family 2 Fa1 Mo1 Pa1 Fa2 Mo2 Pa2 Pa3 R126L ー / ー ー / ー +/ ー ー / ー ー / ー ー / ー ー / ー K256V ー / ー ー /+ +/+ ー / ー ー / ー ー / ー ー / ー R468W ー / ー ー /+ +/+ ー /+ ー /+ +/+ +/+ Uptake 100% 87% 36% 83% 84% 66% 63% Phenotype Healthy Healthy Severe Healthy Healthy Mild Minimal

The Brain Glucose Demands in Normal Children Fetus 3 to 4 yrs 10 s Adulthood

SUMMARY l In GLUT1-DS, there are variations in clinical phenotype and severity due to differences in gene mutations and residual function of GLUT1 protein. l Additionally, heterogeneity in clinical phenotype and severity is present not only among unrelated patients but also among patients within a family bearing the same autosomal dominant mutation. l The glucose demands of the brain vary with age. There are also agedependent differences in the symptoms. l Familial cases of GLUT1-DS may manifest asymptomatic to mild phenotypes in terms of intellectual disability and/or epilepsy in early generations, whereas more severe phenotypes and earlier onset ages appear in the next generations, showing an anticipation phenomenon. l Therefore, the mechanism of GLUT1-DS pathogenesis appears to be highly complex.